News
Public · Published
Syngene International Q2 Results: Net profit tanks 52% on lower Zoetis revenue, forex hedge losses
Syngene International reported a 52% year-on-year fall in net profit to ₹32 crore for the second quarter of financial year 2026-27, down from ₹67 crore. Revenue fell 8.6% to ₹833 crore, and EBITDA declined 26% to ₹147.4 crore.
Published:
Updated:
What happened
Syngene International reported a 52% year-on-year fall in net profit to ₹32 crore for the second quarter of financial year 2026-27, down from ₹67 crore. Revenue fell 8.6% to ₹833 crore, and EBITDA declined 26% to ₹147.4 crore.
Confirmed
Global impact / market context
Lower Zoetis revenue and forex hedge losses, which are losses on contracts meant to offset currency swings, cut profit sharply. A narrower EBITDA margin, meaning less profit per sale after running costs, signals weaker operating efficiency and could pressure investor confidence.
Analyst inference
The results point to softer demand from a key client and currency-related costs hurting earnings. With profit down by half, investors may question near-term earnings stability, even as management points to early progress in its CDMO business, which is contract drug development and manufacturing.
Analyst inference
What to watch
- Watch whether Zoetis-related revenue recovers in coming quarters, since lower Zoetis revenue was cited as a reason for the profit decline. Confirmed
- Management plans to emphasize differentiated, high-value services and CDMO capabilities, so watch whether these efforts translate into revenue growth. Proposed
- Track forex hedge losses and EBITDA margin trends, because currency contracts and weaker profit per sale could keep weighing on earnings. Analyst inference
Evidence
- Original source link unavailable